PRFX PainReform Limited Sotuvning yalpi rentabelligi

PainReform Limited (PRFX) kompaniyasining rasmiy ramzlari

PainReform Ltd. bemorlarning qulay tiklanishi uchun xavfsiz vositalarni yaratish orqali jarrohlar orasida e'tirof etilmoqda. PRF-110 ishlanmasi uzoq muddatli og'riqni qoldirish orqali opioidga bog'liqlikni minimallashtirish uchun mo'ljallangan. Ekologik toza sintez va etika qoidalariga rioya qilish o'sish strategiyasini to'ldiradi. GURU.Markets platformasida yalpi foyda marjasini baholagach, -3716.10 joriy metrika qiymatini tashkil etishini aniqladik.

PRFX (PainReform Limited) Yalpi marja tarixi 04.07.2022dan 19.11.2026gacha

PainReform Ltd (PRFX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Kompaniyaning asosiy tahlili:PainReform Ltd (PRFX)
PainReform tovar namunasi

PainReform Ltd. (PRFX) tomonidan patentlangan dori yetkazib berish tizimlarining ommaviy ishlab chiqarilishi yuqori biznes kengayuvchanligi bilan bir qatorda sotilgan tovarlarning minimal xarajatlarini ta'minlaydi. Valole foyda bevosita ishlab chiqarish xarajatlarini qoplashdan keyin qolgan daromad qismini o'lchaydi, bu esa kompaniyaning foyda keltirish bo'yicha fundamental qobiliyatini belgilaydi. Daromadga nisbatan yalpi foyda darajasini tahlil qilish investorlarga bozor shovqinlarini filtrlash va operatsion modelning haqiqiy samaradorligini baholash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|ORMP - Yalpi foyda marjasi|Yalpi marja ENTX (Entera Bio)|Sotuvning yalpi marjinal rentabelligi MindWalk Therapeutics|ABVC: Yalpi foyda bo'yicha rentabellik|CPIX - Yalpi marja|QNTM (Quantum BioPharma) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Yalpi marja|Yalpi marja ranitherapeutics.com|Yalpi rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Sotuvning yalpi rentabelligi|lexariabioscience.com - Yalpi foyda bo'yicha rentabellik|Yalpi marja Pulmatrix Inc PULM|Pheton Holdings - Yalpi marja|Yalpi foyda bo'yicha marjinallik APM|Lyra Therapeutics, Inc. (LYRA) - Yalpi rentabellik|Yalpi foyda marjasi Impact BioMedical, Inc. (IBO)|Yalpi rentabellik TNF Pharma|YCBD: Yalpi foyda normasi|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja